Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-06-01-2001
Volume0
Issue 0

Relocation: Coming to America

Author(s):

Kevin Gopal

Berlin, Germany-Putting the US market at the heart of its bid to maintain double-digit growth, last month Schering began to relocate its therapeutics headquarters to an existing facility in Montville, New Jersey.

Articles in this issue
Industry Under Investigation
Emotion - The New Brand Integrator
For Love of the Game
Field of Dreams
Workshop: Access Options
Emotion - The New Brand Integrator
Rx-to-OTC: Unwanted Attention
Emotion - Biotech Renaissance Man
Relocation: Coming to America
Stocks: Catching the Market Blues
Gathering Light

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Robert Lisicki
Gen Li
Gen Li
Dr. Ben Zeskind
Gen Li
Dr. Ben Zeskind
Gen Li
Related Content
Harshit Jain, MD
August 5th 2025

From Scatter to Scale: Rethinking Marketing/Programmatic Strategy for Amplified HCP Reach and Engagement

Harshit Jain
One of the most significant drawbacks for a brand when partnering with individual medical journal platforms is the limitation in reach and scalability they possess.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 5th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Stock.adobe.com
August 5th 2025

Sanofi Purchases $130 million Exclusive License for Plozasiran from Visirna Therapeutics

Nicholas Jacobus
Sanofi secures exclusive rights to develop plozasiran in Greater China, enhancing treatment options for hypertriglyceridemia and expanding its cardiometabolic portfolio.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
August 5th 2025

Beyond the Prescription: Pharma's Role in Digital Health Conversations

Canopy
Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Stock.adobe.com
August 5th 2025

Umbilical-Derived Stem Cells and the Knee: A Q&A with Edward Ahn

The Medipost CEO discusses developing treatments for knee osteoarthritis and other conditions.
GAIN Therapeutics Ramps Up for Next Big Step in Parkinson’s Drug Development
August 5th 2025

GAIN Therapeutics Ramps Up for Next Big Step in Parkinson’s Drug Development

Don Tracy, Associate Editor
Gene Mack, CEO, GAIN Therapeutics, outlines how early trial results for GT-02287 are shaping the company’s strategy for advancing a potential new treatment for Parkinson’s disease.